更多...
收起
This gene encodes glucocorticoid receptor, which can function both as a transcription factor that binds to glucocorticoid response elements in the promoters of glucocorticoid responsive genes to activate their transcription, and as a regulator of other transcription factors. This receptor is typically found in the cytoplasm, but upon ligand binding, is transported into the nucleus. It is involved in inflammatory responses, cellular proliferation, and differentiation in target tissues. Mutations in this gene are associated with generalized glucocorticoid resistance. Alternative splicing of this gene results in transcript variants encoding either the same or different isoforms. Additional isoforms resulting from the use of alternate in-frame translation initiation sites have also been described, and shown to be functional, displaying diverse cytoplasm-to-nucleus trafficking patterns and distinct transcriptional activities (PMID:15866175). [provided by RefSeq, Feb 2011]
[中文简述(自动翻译):]  这个基因编码糖皮质激素受体,它可以既充当结合在糖皮质激素反应性基因的启动子糖皮质激素反应元件以激活其转录的转录因子,并作为其他转录因子的调节器。这种受体是在细胞质中通常发现,但在配体结合,被转运到细胞核。它参与炎症反应,细胞增殖和分化中的靶组织。在这种基因突变与广义的糖皮质激素抗性相关。在转录此基因的结果的选择性剪接变体编码相同或不同的同种型。从使用备用的在帧翻译起始位点也被描述,并证明是功能性的,显示多样细胞质至细胞核贩卖的模式和不同的转录活性(:15866175 PMID)所得附加同种型。 [由RefSeq的,2011年2月提供]
NR3C1基因(以及对应的蛋白质)的细胞分布位置:
NR3C1基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Glucocorticoid Receptor Deficiency | 0.255743629 | 59 | 2 | BeFree_ORPHANET_UNIPROT |
Hypertensive disease | 0.213821129 | 14 | 0 | BeFree_CTD_human_GAD_LHGDN_RGD |
Depressive disorder | 0.208414698 | 33 | 1 | BeFree_CTD_human_RGD |
Bipolar Disorder | 0.129705894 | 18 | 0 | BeFree_CTD_human_GAD_LHGDN |
Schizophrenia | 0.127262917 | 11 | 0 | BeFree_CTD_human_GAD_LHGDN |
Ocular Hypertension | 0.123267234 | 2 | 1 | BeFree_CTD_human_LHGDN |
Psychotic Disorders | 0.120542884 | 3 | 0 | BeFree_CTD_human |
Endometriosis | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Prostatic Neoplasms | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Lung Diseases, Obstructive | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Hypokalemia | 0.12 | 1 | 0 | CTD_human |
Cocaine-Related Disorders | 0.12 | 2 | 0 | CTD_human |
Pseudohermaphroditism, Female, With Hypokalemia, Due To Glucocorticoid Resistance | 0.12 | 0 | 1 | CLINVAR |
46, XX Disorders of Sex Development | 0.12 | 1 | 0 | CTD_human |
Obesity | 0.109989428 | 38 | 1 | BeFree_GAD_RGD |
Asthma | 0.103678913 | 45 | 3 | BeFree_GAD_LHGDN_RGD |
Rheumatoid Arthritis | 0.095892975 | 13 | 0 | BeFree_GAD_LHGDN_RGD |
Diabetes Mellitus, Non-Insulin-Dependent | 0.086362715 | 8 | 1 | BeFree_GAD_RGD |
Post-Traumatic Stress Disorder | 0.085157396 | 20 | 1 | BeFree_RGD |
Lung diseases | 0.083181358 | 4 | 0 | BeFree_GAD_RGD |
Heart failure | 0.082909916 | 3 | 0 | BeFree_GAD_RGD |
Kidney Failure, Chronic | 0.082367032 | 2 | 0 | GAD_RGD |
Polycystic Ovary Syndrome | 0.081085767 | 5 | 0 | BeFree_RGD |
Sepsis | 0.081085767 | 5 | 0 | BeFree_RGD |
Muscular Atrophy | 0.080271442 | 2 | 0 | BeFree_RGD |
Cerebrovascular accident | 0.080271442 | 2 | 0 | BeFree_RGD |
Uveitis | 0.080271442 | 3 | 0 | BeFree_RGD |
Brain Ischemia | 0.08 | 1 | 0 | RGD |
Edema | 0.08 | 1 | 0 | RGD |
Epilepsy, Temporal Lobe | 0.08 | 1 | 0 | RGD |
Fetal Growth Retardation | 0.08 | 2 | 0 | RGD |
Malocclusion | 0.08 | 1 | 0 | RGD |
Seizures | 0.08 | 1 | 0 | RGD |
Cataract | 0.08 | 1 | 0 | RGD |
Endotoxemia | 0.08 | 1 | 0 | RGD |
Mental Depression | 0.019978416 | 33 | 1 | BeFree_GAD |
Nephrotic Syndrome | 0.016088472 | 4 | 0 | BeFree_GAD_LHGDN |
Cardiovascular Diseases | 0.011639663 | 9 | 1 | BeFree_GAD |
Major Depressive Disorder | 0.010162901 | 21 | 0 | BeFree_GAD |
Chronic Fatigue Syndrome | 0.010011012 | 4 | 0 | BeFree_GAD |
Inflammation | 0.009825446 | 4 | 0 | GAD_LHGDN |
Premature Birth | 0.009825446 | 4 | 0 | GAD_LHGDN |
Mammary Neoplasms | 0.009520329 | 17 | 1 | BeFree_LHGDN |
Adenoma | 0.008729747 | 9 | 0 | BeFree_GAD |
Coronary heart disease | 0.008729747 | 7 | 1 | BeFree_GAD |
Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.00853425 | 15 | 3 | BeFree_GAD |
Multiple Sclerosis | 0.008186863 | 5 | 0 | BeFree_GAD |
Crohn Disease | 0.007915422 | 5 | 0 | BeFree_GAD |
leukemia | 0.007534359 | 11 | 0 | BeFree_GAD_LHGDN |
Atherosclerosis | 0.007372538 | 4 | 0 | BeFree_GAD |
Mood Disorders | 0.007262917 | 9 | 0 | BeFree_GAD_LHGDN |
Insulin Resistance | 0.007101096 | 3 | 0 | GAD |
Fatigue | 0.006720033 | 6 | 1 | BeFree_GAD_LHGDN |
Coronary Artery Disease | 0.00617715 | 4 | 1 | BeFree_GAD_LHGDN |
Unipolar Depression | 0.005700279 | 21 | 0 | BeFree |
Diabetes Mellitus | 0.00554839 | 4 | 1 | BeFree_GAD |
Cystic Fibrosis | 0.005362824 | 1 | 0 | BeFree_GAD_LHGDN |
Thyroid associated opthalmopathies | 0.005362824 | 1 | 0 | BeFree_GAD_LHGDN |
Metabolic Syndrome X | 0.005352893 | 11 | 1 | BeFree_GAD |
Cerebral Infarction | 0.005091382 | 1 | 0 | GAD_LHGDN |
Adrenal Gland Neoplasms | 0.005005506 | 3 | 0 | BeFree_GAD |
Small cell carcinoma of lung | 0.004895885 | 8 | 0 | BeFree_LHGDN |
Congenital adrenal hyperplasia | 0.004734064 | 2 | 0 | GAD |
Infection | 0.004734064 | 2 | 0 | GAD |
Nasal Polyps | 0.004624443 | 7 | 0 | BeFree_LHGDN |
Malignant neoplasm of breast | 0.004614512 | 17 | 0 | BeFree |
Breast Carcinoma | 0.004614512 | 17 | 0 | BeFree |
Lupus Erythematosus, Systemic | 0.004353001 | 6 | 0 | BeFree_LHGDN |
Pituitary Diseases | 0.00434307 | 16 | 0 | BeFree |
Acute lymphocytic leukemia | 0.004071628 | 15 | 3 | BeFree |
Coronary Arteriosclerosis | 0.003995683 | 6 | 1 | BeFree_GAD |
Leukemia, Lymphocytic, Acute, L1 | 0.003800186 | 14 | 1 | BeFree |
Inflammatory Bowel Diseases | 0.003724241 | 5 | 0 | BeFree_GAD |
Multiple Myeloma | 0.003528744 | 13 | 0 | BeFree |
Ulcerative Colitis | 0.003452799 | 5 | 0 | BeFree_GAD |
Metabolic Diseases | 0.003267234 | 3 | 0 | BeFree_LHGDN |
Addison Disease | 0.003181358 | 4 | 0 | BeFree_GAD |
Cushing Syndrome | 0.003181358 | 3 | 0 | BeFree_GAD |
Chronic Obstructive Airway Disease | 0.003181358 | 3 | 0 | BeFree_GAD |
Myocardial Infarction | 0.003181358 | 3 | 0 | BeFree_GAD |
Hyperandrogenism | 0.003181358 | 3 | 0 | BeFree_GAD |
Pituitary-dependent Cushing's disease | 0.002995792 | 2 | 1 | BeFree_LHGDN |
Lymphoid leukemia | 0.002909916 | 3 | 0 | BeFree_GAD |
Respiratory Syncytial Virus Infections | 0.002909916 | 3 | 0 | BeFree_GAD |
Dyslipidemias | 0.002909916 | 3 | 0 | BeFree_GAD |
Dementia | 0.002909916 | 2 | 0 | BeFree_GAD |
Muscular Dystrophy, Duchenne | 0.00272435 | 1 | 0 | LHGDN |
Hypoglycemia | 0.00272435 | 1 | 0 | LHGDN |
Lung Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
Septic Shock | 0.00272435 | 1 | 0 | LHGDN |
Sleep Apnea, Obstructive | 0.00272435 | 1 | 0 | LHGDN |
HIV Infections | 0.002714419 | 10 | 0 | BeFree |
Guillain-Barre Syndrome | 0.002638474 | 1 | 0 | BeFree_GAD |
Hypercholesterolemia | 0.002638474 | 2 | 0 | BeFree_GAD |
Obesity, Morbid | 0.002638474 | 2 | 0 | BeFree_GAD |
Pituitary Neoplasms | 0.002638474 | 2 | 0 | BeFree_GAD |
Respiratory Distress Syndrome, Newborn | 0.002638474 | 2 | 0 | BeFree_GAD |
Retinal Diseases | 0.002638474 | 1 | 1 | BeFree_GAD |
HELLP Syndrome | 0.002638474 | 1 | 0 | BeFree_GAD |
Colorectal Cancer | 0.002638474 | 2 | 0 | BeFree_GAD |
Carcinogenesis | 0.002442977 | 9 | 0 | BeFree |
Prostate carcinoma | 0.002442977 | 9 | 0 | BeFree |
Abortion, Habitual | 0.002367032 | 1 | 0 | GAD |
Bronchiolitis, Viral | 0.002367032 | 1 | 0 | GAD |
Celiac Disease | 0.002367032 | 1 | 0 | GAD |
Cerebral Arterial Diseases | 0.002367032 | 1 | 0 | GAD |
Connective Tissue Diseases | 0.002367032 | 1 | 0 | GAD |
Fetal Diseases | 0.002367032 | 1 | 0 | GAD |
Glaucoma, Open-Angle | 0.002367032 | 1 | 0 | GAD |
Growth Disorders | 0.002367032 | 1 | 0 | GAD |
Female infertility | 0.002367032 | 1 | 0 | GAD |
Lymphoma, Non-Hodgkin | 0.002367032 | 1 | 0 | GAD |
Musculoskeletal Diseases | 0.002367032 | 1 | 0 | GAD |
Musculoskeletal Pain | 0.002367032 | 1 | 0 | GAD |
Myasthenia Gravis | 0.002367032 | 1 | 0 | GAD |
Nelson Syndrome | 0.002367032 | 1 | 0 | GAD |
Bone necrosis | 0.002367032 | 1 | 0 | GAD |
Osteoporosis | 0.002367032 | 1 | 0 | GAD |
Osteoporosis, Postmenopausal | 0.002367032 | 1 | 0 | GAD |
Pregnancy Complications, Hematologic | 0.002367032 | 1 | 0 | GAD |
Proteinuria | 0.002367032 | 1 | 0 | GAD |
Pseudomonas Infections | 0.002367032 | 1 | 0 | GAD |
Psychophysiologic Disorders | 0.002367032 | 1 | 0 | GAD |
Dermatologic disorders | 0.002367032 | 1 | 0 | GAD |
Stress | 0.002367032 | 1 | 0 | GAD |
Weight Gain | 0.002367032 | 1 | 0 | GAD |
Ventricular Dysfunction | 0.002367032 | 1 | 0 | GAD |
Precocious pubarche | 0.002367032 | 1 | 0 | GAD |
Lupus Erythematosus | 0.002367032 | 1 | 0 | GAD |
body mass | 0.002367032 | 1 | 0 | GAD |
Skin carcinoma | 0.002367032 | 1 | 0 | GAD |
Blood pressure finding | 0.002367032 | 1 | 0 | GAD |
Systemic arterial pressure | 0.002367032 | 1 | 0 | GAD |
Proteinuria Adverse Event | 0.002367032 | 1 | 0 | GAD |
Weight Gain Adverse Event | 0.002367032 | 1 | 0 | GAD |
Chronic ulcerative colitis | 0.002367032 | 1 | 0 | GAD |
Anxiety Disorders | 0.002171535 | 8 | 0 | BeFree |
Drug abuse | 0.002171535 | 8 | 0 | BeFree |
Malignant neoplasm of prostate | 0.002171535 | 8 | 0 | BeFree |
Mental disorders | 0.001628651 | 6 | 0 | BeFree |
Borderline Personality Disorder | 0.001628651 | 6 | 0 | BeFree |
Depressive Symptoms | 0.001357209 | 5 | 0 | BeFree |
Obesity, Abdominal | 0.001357209 | 5 | 1 | BeFree |
ACTH-Secreting Pituitary Adenoma | 0.001357209 | 5 | 1 | BeFree |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.001357209 | 5 | 0 | BeFree |
Liver carcinoma | 0.001357209 | 5 | 0 | BeFree |
Osteosarcoma | 0.001085767 | 4 | 0 | BeFree |
Ovarian Carcinoma | 0.001085767 | 4 | 0 | BeFree |
Pituitary Adenoma | 0.001085767 | 4 | 0 | BeFree |
Septicemia | 0.001085767 | 4 | 0 | BeFree |
Hematologic Neoplasms | 0.001085767 | 4 | 0 | BeFree |
Osteosarcoma of bone | 0.001085767 | 4 | 0 | BeFree |
Precursor B-cell lymphoblastic leukemia | 0.001085767 | 4 | 0 | BeFree |
Primary cortisol resistance | 0.001085767 | 4 | 0 | BeFree |
Adrenal Gland Hyperfunction | 0.000814326 | 3 | 0 | BeFree |
Autoimmune Diseases | 0.000814326 | 3 | 0 | BeFree |
Malignant tumor of colon | 0.000814326 | 3 | 0 | BeFree |
Eating Disorders | 0.000814326 | 3 | 2 | BeFree |
Hyperinsulinism | 0.000814326 | 3 | 0 | BeFree |
Chronic Lymphocytic Leukemia | 0.000814326 | 3 | 0 | BeFree |
Liver neoplasms | 0.000814326 | 3 | 0 | BeFree |
Lymphoma | 0.000814326 | 3 | 0 | BeFree |
Neoplasm Metastasis | 0.000814326 | 3 | 0 | BeFree |
Chronic sinusitis | 0.000814326 | 3 | 0 | BeFree |
Overweight | 0.000814326 | 3 | 1 | BeFree |
Chronic active hepatitis | 0.000814326 | 3 | 0 | BeFree |
Epithelial ovarian cancer | 0.000814326 | 3 | 0 | BeFree |
Colon Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of ovary | 0.000814326 | 3 | 0 | BeFree |
Inflammatory disorder | 0.000814326 | 3 | 0 | BeFree |
Bulimia Nervosa | 0.000814326 | 3 | 0 | BeFree |
ACTH Syndrome, Ectopic | 0.000542884 | 2 | 0 | BeFree |
Primary Myelofibrosis | 0.000542884 | 2 | 0 | BeFree |
Alzheimer's Disease | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of urinary bladder | 0.000542884 | 2 | 0 | BeFree |
Bronchopulmonary Dysplasia | 0.000542884 | 2 | 0 | BeFree |
Renal Cell Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Squamous cell carcinoma | 0.000542884 | 2 | 0 | BeFree |
Colorectal Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Presenile dementia | 0.000542884 | 2 | 0 | BeFree |
Diabetes | 0.000542884 | 2 | 0 | BeFree |
Drug habituation | 0.000542884 | 2 | 0 | BeFree |
Fibromyalgia | 0.000542884 | 2 | 0 | BeFree |
Fibrosarcoma | 0.000542884 | 2 | 0 | BeFree |
Glaucoma | 0.000542884 | 2 | 0 | BeFree |
Congestive heart failure | 0.000542884 | 2 | 0 | BeFree |
Hypercholesterolemia, Familial | 0.000542884 | 2 | 0 | BeFree |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.000542884 | 2 | 0 | BeFree |
Lupus Nephritis | 0.000542884 | 2 | 0 | BeFree |
Meningioma | 0.000542884 | 2 | 0 | BeFree |
Degenerative polyarthritis | 0.000542884 | 2 | 0 | BeFree |
Ovarian Diseases | 0.000542884 | 2 | 0 | BeFree |
Polycythemia Vera | 0.000542884 | 2 | 0 | BeFree |
polyps | 0.000542884 | 2 | 0 | BeFree |
Respiratory Distress Syndrome, Adult | 0.000542884 | 2 | 0 | BeFree |
Kaposi Sarcoma | 0.000542884 | 2 | 0 | BeFree |
West Syndrome | 0.000542884 | 2 | 0 | BeFree |
Stress, Psychological | 0.000542884 | 2 | 0 | BeFree |
Virilism | 0.000542884 | 2 | 1 | BeFree |
Virus Diseases | 0.000542884 | 2 | 0 | BeFree |
Essential Hypertension | 0.000542884 | 2 | 0 | BeFree |
Malnutrition | 0.000542884 | 2 | 0 | BeFree |
Hypomania | 0.000542884 | 2 | 0 | BeFree |
Impaired glucose tolerance | 0.000542884 | 2 | 0 | BeFree |
Impaired cognition | 0.000542884 | 2 | 0 | BeFree |
Manic | 0.000542884 | 2 | 0 | BeFree |
Nonorganic psychosis | 0.000542884 | 2 | 0 | BeFree |
Pre B-cell acute lymphoblastic leukemia | 0.000542884 | 2 | 0 | BeFree |
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site | 0.000542884 | 2 | 0 | BeFree |
Immune thrombocytopenic purpura | 0.000542884 | 2 | 0 | BeFree |
Hepatitis B, Chronic | 0.000542884 | 2 | 0 | BeFree |
Intraocular pressure disorder | 0.000542884 | 2 | 0 | BeFree |
Carcinoma of bladder | 0.000542884 | 2 | 0 | BeFree |
21-hydroxylase deficiency | 0.000542884 | 2 | 1 | BeFree |
social stress | 0.000542884 | 2 | 1 | BeFree |
Adrenal incidentaloma | 0.000542884 | 2 | 1 | BeFree |
Obesity, Visceral | 0.000542884 | 2 | 0 | BeFree |
Congenital adrenal hyperplasia due to 21 hydroxylase deficiency | 0.000542884 | 2 | 1 | BeFree |
Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Alcoholic Intoxication | 0.000271442 | 1 | 0 | BeFree |
Amenorrhea | 0.000271442 | 1 | 0 | BeFree |
Melanoma, B16 | 0.000271442 | 1 | 0 | BeFree |
Bladder Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Bronchiolitis | 0.000271442 | 1 | 0 | BeFree |
Non-Small Cell Lung Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Carcinoma, Transitional Cell | 0.000271442 | 1 | 0 | BeFree |
Cholestasis | 0.000271442 | 1 | 0 | BeFree |
Bronchitis, Chronic | 0.000271442 | 1 | 0 | BeFree |
Phyllodes Tumor | 0.000271442 | 1 | 0 | BeFree |
Delirium | 0.000271442 | 1 | 0 | BeFree |
Dyspnea, Paroxysmal | 0.000271442 | 1 | 0 | BeFree |
Epilepsies, Partial | 0.000271442 | 1 | 0 | BeFree |
Esophageal Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Failure to Thrive | 0.000271442 | 1 | 1 | BeFree |
Glioma | 0.000271442 | 1 | 0 | BeFree |
Herpes Simplex Infections | 0.000271442 | 1 | 0 | BeFree |
Von Hippel-Lindau Syndrome | 0.000271442 | 1 | 0 | BeFree |
Hunger | 0.000271442 | 1 | 0 | BeFree |
Immune System Diseases | 0.000271442 | 1 | 0 | BeFree |
Keloid | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of stomach | 0.000271442 | 1 | 0 | BeFree |
Melancholia | 0.000271442 | 1 | 0 | BeFree |
Myelofibrosis | 0.000271442 | 1 | 0 | BeFree |
Myositis | 0.000271442 | 1 | 0 | BeFree |
Neuroblastoma | 0.000271442 | 1 | 0 | BeFree |
Oppositional Defiant Disorder | 0.000271442 | 1 | 1 | BeFree |
Pain | 0.000271442 | 1 | 0 | BeFree |
Pheochromocytoma | 0.000271442 | 1 | 0 | BeFree |
Pneumonia | 0.000271442 | 1 | 0 | BeFree |
Polycythemia | 0.000271442 | 1 | 0 | BeFree |
Rheumatism | 0.000271442 | 1 | 0 | BeFree |
Sarcoidosis | 0.000271442 | 1 | 0 | BeFree |
Thrombocythemia, Essential | 0.000271442 | 1 | 0 | BeFree |
Tuberculosis | 0.000271442 | 1 | 0 | BeFree |
Turner Syndrome | 0.000271442 | 1 | 0 | BeFree |
Violence | 0.000271442 | 1 | 0 | BeFree |
Gestational Diabetes | 0.000271442 | 1 | 0 | BeFree |
Liver Failure | 0.000271442 | 1 | 0 | BeFree |
Polymyositis | 0.000271442 | 1 | 0 | BeFree |
Alcohol abuse | 0.000271442 | 1 | 0 | BeFree |
Esophageal carcinoma | 0.000271442 | 1 | 0 | BeFree |
Recurrent major depressive episodes | 0.000271442 | 1 | 0 | BeFree |
Agenesis of corpus callosum | 0.000271442 | 1 | 0 | BeFree |
Diastrophic dysplasia | 0.000271442 | 1 | 0 | BeFree |
Depression, Postpartum | 0.000271442 | 1 | 0 | BeFree |
Psychological symptom | 0.000271442 | 1 | 1 | BeFree |
Inclusion Body Myositis (disorder) | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of lung | 0.000271442 | 1 | 0 | BeFree |
Mandibulofacial Dysostosis | 0.000271442 | 1 | 0 | BeFree |
Generalized Anxiety Disorder | 0.000271442 | 1 | 0 | BeFree |
Somatotropin deficiency | 0.000271442 | 1 | 0 | BeFree |
T-cell childhood acute lymphoblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
Conventional (Clear Cell) Renal Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Solid tumour | 0.000271442 | 1 | 0 | BeFree |
Acute Undifferentiated Leukemia | 0.000271442 | 1 | 0 | BeFree |
Cushingoid facies | 0.000271442 | 1 | 0 | BeFree |
Steroid-sensitive nephrotic syndrome | 0.000271442 | 1 | 2 | BeFree |
Anovulatory | 0.000271442 | 1 | 0 | BeFree |
Symptoms of stress | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of esophagus | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma of skin | 0.000271442 | 1 | 0 | BeFree |
Aqueous Humor Disorders | 0.000271442 | 1 | 0 | BeFree |
Refractory cancer | 0.000271442 | 1 | 0 | BeFree |
Carcinoma of lung | 0.000271442 | 1 | 0 | BeFree |
Stomach Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Central neuroblastoma | 0.000271442 | 1 | 0 | BeFree |
Idiopathic Inflammatory Myopathies | 0.000271442 | 1 | 0 | BeFree |
Adult Acute Lymphocytic Leukemia | 0.000271442 | 1 | 0 | BeFree |
Growth failure | 0.000271442 | 1 | 1 | BeFree |
Ovarian adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Hurthle Cell Tumor | 0.000271442 | 1 | 0 | BeFree |
Arthritis, Collagen-Induced | 0.000271442 | 1 | 0 | BeFree |
Attention deficit hyperactivity disorder | 0.000271442 | 1 | 0 | BeFree |
Chromophobe Renal Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Liver regeneration disorder | 0.000271442 | 1 | 0 | BeFree |
Hormone refractory prostate cancer | 0.000271442 | 1 | 0 | BeFree |
Childhood Leukemia | 0.000271442 | 1 | 0 | BeFree |
Metaplastic breast carcinoma | 0.000271442 | 1 | 0 | BeFree |
Sporadic Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Oncocytic Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Vascular lesions | 0.000271442 | 1 | 0 | BeFree |
Oxyphilic Adenoma | 0.000271442 | 1 | 0 | BeFree |
Erythrocytosis | 0.000271442 | 1 | 0 | BeFree |
Estrogen receptor positive tumor | 0.000271442 | 1 | 0 | BeFree |
androgen independent prostate cancer | 0.000271442 | 1 | 0 | BeFree |
Non-Neoplastic Disorder | 0.000271442 | 1 | 0 | BeFree |
Meningioma, benign, no ICD-O subtype | 0.000271442 | 1 | 0 | BeFree |
MAJOR AFFECTIVE DISORDER 2 | 0.000271442 | 1 | 0 | BeFree |
BODY COMPOSITION, BENEFICIAL | 0.000271442 | 1 | 0 | BeFree |
MAJOR AFFECTIVE DISORDER 1 | 0.000271442 | 1 | 0 | BeFree |
Paroxysmal nocturnal dyspnea | 0.000271442 | 1 | 0 | BeFree |
MAJOR AFFECTIVE DISORDER 4 | 0.000271442 | 1 | 0 | BeFree |
MAJOR AFFECTIVE DISORDER 5 | 0.000271442 | 1 | 0 | BeFree |
MAJOR AFFECTIVE DISORDER 6 | 0.000271442 | 1 | 0 | BeFree |
Urothelial Carcinoma | 0.000271442 | 1 | 0 | BeFree |
MAJOR AFFECTIVE DISORDER 7 | 0.000271442 | 1 | 0 | BeFree |
MAJOR AFFECTIVE DISORDER 8 | 0.000271442 | 1 | 0 | BeFree |
MAJOR AFFECTIVE DISORDER 9 | 0.000271442 | 1 | 0 | BeFree |
Cortisol 11-beta-ketoreductase deficiency | 0.000271442 | 1 | 0 | BeFree |
Triple Negative Breast Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Isolated somatotropin deficiency | 0.000271442 | 1 | 0 | BeFree |
Lymphoblastic leukemia in children | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。